CREB3L1 and renal cell carcinoma: In the current study, we used a mouse xenograft model of renal cell carcinoma (RCC), which exhibits the same drug sensitivity as that displayed in patients [6], to demonstrate that doxorubicin inhibited growth of tumors that produced CREB3L1 but not those that did not express the protein.